Endometriosis with a pleural effusion and ascites. Report of a case treated with nafarelin acetate

Shek Y, Y. Shek, J. E. De Lia, De Lia JE, R A Pattillo, Pattillo RA, Roland A. Pattillo
The Journal of reproductive medicine · 1995 · vol. 40(7) , pp. 540–2 · PMID:7473446 · W2414193584
Case report OA: closed CC0 ⤵ 10 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This case report describes a 21-year-old woman with endometriosis, pleural effusion, and ascites, who experienced significant improvement following treatment with nafarelin acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Although endometriosis is generally confined to the pelvis, it may occur at remote sites with unusual manifestations. Rare examples include pulmonary endometriosis and endometriosis associated with ascites. These complications represent diagnostic and therapeutic dilemmas, especially when both occur concurrently in the same patient. CASE: A 21-year-old nulligravida had a history of endometriosis and complained of severe dyspnea and weight loss. Pleural effusion and pelvic ascites associated with recurrent endometriosis were found. The patient was treated with thoracentesis and nafarelin acetate nasal spray. A remarkable improvement in her condition occurred, and the side effects of the spray were minimal during treatment. CONCLUSION: Gonadotropin-releasing hormone agonist therapy is recommended as the initial treatment for endometriotic ascites and/or pleural effusion.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Ascites Endometriosis Nafarelin Pleural Effusion Adult Adult Ascites Ascites Ascites Endometriosis Endometriosis Endometriosis Female Female Humans Humans Nafarelin Nafarelin Pleural Effusion Pleural Effusion

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (10)

Source provenance

europepmc
last seen: 2026-10-09T06:09:53.026058+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:49.153990+00:00
License: CC0 · commercial use OK